Dexcom G7 vs Libre 3 Plus: Which Prescription CGM Is Better in 2026?
The Dexcom G7 and Abbott FreeStyle Libre 3 Plus are the two most popular prescription CGMs in the United States, and both deliver real-time continuous glucose data with high accuracy. The G7 offers a 10.9% MARD with customizable high/low alerts, predictive urgent low alerts, and broad insulin pump compatibility (Omnipod 5, Tandem t:slim X2). The Libre 3 Plus counters with a 7.9% MARD (best-in-class accuracy), a 15-day wear time vs the G7's 10 days, and a significantly lower retail price. Both have smartphone apps, data sharing, and water resistance. The G7 is FDA-approved for ages 2+, while the Libre 3 Plus is approved for ages 4+.
This head-to-head comparison evaluates 11 specification categories: MARD accuracy, sensor wear time, warmup time, calibration requirements, alert capability, insulin pump compatibility, prescription requirement, insured and uninsured pricing, Medicare coverage, and overall GlucoseIntel rating. Each spec is compared in the table below, with the superior value highlighted. Where the difference is negligible or depends on individual preference, neither value is highlighted.
Dexcom G7 vs FreeStyle Libre 3 Plus: Specification Comparison
| Spec | Dexcom G7 | FreeStyle Libre 3 Plus |
|---|---|---|
| MARD (Accuracy) | 8.2% | 7.9% |
| Wear Time | 10 days | 15 days |
| Warmup Time | 30 min | 60 min |
| Calibration Required | No | No |
| Alerts & Alarms | Yes | Yes |
| Pump Compatible | Yes | No |
| Prescription Required | Yes | Yes |
| Price (Insured) | $20–$40 per month | $15–$30 per month |
| Price (Uninsured) | $250–$350 per month | $75–$150 per month |
| Medicare | Yes | Yes |
| Rating | 4.8 | 4.7 |
Feature-by-Feature Analysis
Accuracy (MARD)
The FreeStyle Libre 3 Plus is more accurate with a 7.9% MARD versus 8.2% for the Dexcom G7. This 0.3 percentage point difference translates to closer alignment with blood glucose values, particularly important for insulin dosing decisions and overnight monitoring when precision matters most.
Wear Time
The Dexcom G7 lasts 10 days while the FreeStyle Libre 3 Plus lasts 15 days. The FreeStyle Libre 3 Plus's longer wear time means fewer sensor changes per year (approximately 25 vs 37), less insertion discomfort, and potentially lower annual costs.
Cost
With insurance, the Dexcom G7 costs $20–$40 per month per month while the FreeStyle Libre 3 Plus costs $15–$30 per month. Without insurance, the Dexcom G7 costs $250–$350 per month and the FreeStyle Libre 3 Plus costs $75–$150 per month. Both devices are Medicare-approved.
Alerts and Alarms
Both the Dexcom G7 and FreeStyle Libre 3 Plus offer customizable high and low glucose alerts, including predictive urgent low alerts that warn before glucose drops below 55 mg/dL. Alert-capable CGMs are essential for type 1 diabetes patients and anyone at risk of nocturnal hypoglycemia. The quality and customizability of alerts — adjustable thresholds, snooze duration, vibration vs audible — varies between devices and should be evaluated based on your specific alerting needs.
Insulin Pump Compatibility
The Dexcom G7 integrates with insulin pumps (Omnipod 5, Tandem t:slim X2, Tandem Mobi) for closed-loop automated insulin delivery. The FreeStyle Libre 3 Plus is not compatible with any insulin pump system. For type 1 diabetes patients using or planning to use an insulin pump, this makes the Dexcom G7 the only viable option between these two devices.
Who Should Choose Each Device
Choose the Dexcom G7 if: you prioritize this device's specific feature set, need insulin pump integration with Omnipod 5, or are on Medicare.
Choose the FreeStyle Libre 3 Plus if: you prioritize higher accuracy, or are on Medicare.
Verdict
Winner: tie
This comparison is a genuine tie because each device leads in different categories. The Dexcom G7 wins on alert customization, predictive low alerts, and insulin pump integration — making it the better choice for type 1 diabetes and insulin-dependent patients who need automated insulin delivery. The Libre 3 Plus wins on accuracy (7.9% vs 10.9% MARD), wear time (15 vs 10 days), and cost (roughly 30-40% cheaper without insurance). For cost-conscious patients with type 2 diabetes who prioritize accuracy and fewer sensor changes, the Libre 3 Plus is the stronger pick.
Key Takeaways
- Dexcom G7 and Abbott FreeStyle Libre 3 Plus serve different segments of the CGM market.
- The winner (tie) offers the better combination of accuracy, features, and value for most users.
- Your individual needs — insurance coverage, pump compatibility, and whether you need alerts — should drive the final decision.
- Both options are viable choices. Read the full reviews linked below for complete specifications and detailed analysis.